Select Page

Zokinvy (lonafarnib)
Managed Access Program

 

Zokinvy (lonafarnib) Managed Access Program Launched!

We are thrilled to announce that, as of August 2019, the Zokinvy (lonafarnib) Managed Access Program (MAP) is now up and running. PRF and Zokinvy (lonafarnib) manufacturer, Eiger BioPharmaceuticals, have worked together to create this program. The MAP allows eligible children and young adults with Progeria to obtain the drug Zokinvy (lonafarnib) through their local physicians in countries that allow the MAP to be offered.

Please click below for the PDF details in various languages.